Table 1.
Histopathological and clinical parameters of patients with RCC
| Patient characteristics | All RCC all tumours | % |
|---|---|---|
|
Total |
106 |
100% |
|
Patients |
|
|
| Age (mean; ± SD) |
63.7 (11.8) |
|
| Male |
68 |
64.2% |
| Female |
38 |
35.8% |
|
Histology |
|
|
| Clear cell |
77 |
72.6% |
| Papillary |
22 |
20.7% |
| Chromophobe |
5 |
4.7% |
| Other/not classified |
2 |
1.9% |
|
Stage |
|
|
| NA |
3 |
2.8% |
| pT1 |
9 |
8.5% |
| pT1a |
32 |
30.2% |
| pT1b |
20 |
18.9% |
| pT2 |
5 |
4.7% |
| pT3 |
3 |
2.8% |
| pT3a |
10 |
9.4% |
| pT3b |
24 |
22.6% |
| pT4 |
0 |
0% |
|
Grade |
|
|
| G1 |
17 |
16% |
| G1-2 |
15 |
14.2% |
| G2 |
57 |
53.8% |
| G2-3 |
7 |
6.6% |
| G3 |
10 |
9.4% |
|
LN metastasis* |
11 |
10.4% |
|
Visceral metastasis* |
23 |
21.7% |
|
advanced/metastatic disease |
|
|
| (pT3-4 or N+/M+/>G2) | 49 | 46.2% |
∗At time of surgical intervention. SD = standard deviation, LN = lymph node, N+ = lymph node metastasis, M+ = organ metastasis.